Avalon BioVentures SPV I, L.P.

Insider profile

Avalon BioVentures SPV I, L.P.'s trades of Janux Therapeutics, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
47.00
Quantity 161,356
Value US$7,583,732
Transaction date
Proposed sale
Price
45.52
Quantity 46,604
Value US$2,121,414
Transaction date
Proposed sale
Price
41.26
Quantity 110,644
Value US$4,565,171
Transaction date
Proposed sale
Price
54.96
Quantity 691,525
Value US$38,006,214
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-11-01 2024-11-01
PrS Proposed sale
521
260.02
US$473,712 		521 260.02 US$473,712
2024-10-25 2024-10-25
PrS Proposed sale
40,422
73.75
US$2,231,262 		40,422 73.75 US$2,231,262
2024-10-23 2024-10-23
PrS Proposed sale
76,129
334.70
US$2,373,794 		76,129 334.70 US$2,373,794
2024-10-18 2024-10-18
PrS Proposed sale
120,680
50.38
US$6,079,984 		120,680 50.38 US$6,079,984
2024-10-16 2024-10-16
PrS Proposed sale
91,539
49.96
US$4,572,999 		91,539 49.96 US$4,572,999
2024-09-27 2024-09-27
PrS Proposed sale
48,403
46.43
US$2,247,248 		48,403 46.43 US$2,247,248
2024-09-26 2024-09-26
PrS Proposed sale
92,200
47.19
US$4,350,513 		92,200 47.19 US$4,350,513
2024-09-12 2024-09-12
PrS Proposed sale
161,356
47.00
US$7,583,732 		161,356 47.00 US$7,583,732
2024-09-10 2024-09-10
PrS Proposed sale
46,604
45.52
US$2,121,414 		46,604 45.52 US$2,121,414
2024-09-06 2024-09-06
PrS Proposed sale
110,644
41.26
US$4,565,171 		110,644 41.26 US$4,565,171
2024-06-03 2024-06-03
PrS Proposed sale
691,525
54.96
US$38,006,214 		691,525 54.96 US$38,006,214